Departments of Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Amsterdam University Medical Centre, AMC, Amsterdam, the Netherlands.
Br J Surg. 2020 Nov;107(12):1686-1694. doi: 10.1002/bjs.11715. Epub 2020 Jun 10.
Several studies have been published favouring sigmoidectomy with primary anastomosis over Hartmann's procedure for perforated diverticulitis with purulent or faecal peritonitis (Hinchey grade III or IV), but cost-related outcomes were rarely reported. The present study aimed to evaluate costs and cost-effectiveness within the DIVA arm of the Ladies trial.
This was a cost-effectiveness analysis of the DIVA arm of the multicentre randomized Ladies trial, comparing primary anastomosis over Hartmann's procedure for Hinchey grade III or IV diverticulitis. During 12-month follow-up, data on resource use, indirect costs (Short Form Health and Labour Questionnaire) and quality of life (EuroQol Five Dimensions) were collected prospectively, and analysed according to the modified intention-to-treat principle. Main outcomes were incremental cost-effectiveness (ICER) and cost-utility (ICUR) ratios, expressed as the ratio of incremental costs and the incremental probability of being stoma-free or incremental quality-adjusted life-years respectively.
Overall, 130 patients were included, of whom 64 were allocated to primary anastomosis (46 and 18 with Hinchey III and IV disease respectively) and 66 to Hartmann's procedure (46 and 20 respectively). Overall mean costs per patient were lower for primary anastomosis (€20 544, 95 per cent c.i. 19 569 to 21 519) than Hartmann's procedure (€28 670, 26 636 to 30 704), with a mean difference of €-8126 (-14 660 to -1592). The ICER was €-39 094 (95 per cent bias-corrected and accelerated (BCa) c.i. -1213 to -116), indicating primary anastomosis to be more cost-effective. The ICUR was €-101 435 (BCa c.i. -1 113 264 to 251 840).
Primary anastomosis is more cost-effective than Hartmann's procedure for perforated diverticulitis with purulent or faecal peritonitis.
已有多项研究表明,对于伴有脓性或粪便性腹膜炎(Hinchey 分级 III 或 IV 级)的穿孔性憩室炎,与 Hartmann 手术相比,施行乙状结肠切除术加一期吻合术具有优势,但很少有研究报道成本相关的结果。本研究旨在评估 Ladies 试验 DIVA 臂内的成本效益。
这是一项多中心随机 Ladies 试验 DIVA 臂的成本效益分析,比较了 Hartmann 手术与一期吻合术治疗 Hinchey 分级 III 或 IV 级憩室炎的效果。在 12 个月的随访期间,前瞻性收集资源使用、间接成本(简短健康调查问卷和劳动力问卷)和生活质量(EuroQol 五维)数据,并根据改良意向治疗原则进行分析。主要结局为增量成本效益(ICER)和成本效用(ICUR)比,分别表示为增量成本与免于造口或增量质量调整生命年的增量概率的比值。
总共纳入了 130 例患者,其中 64 例患者被分配到行一期吻合术(分别有 46 例和 18 例为 Hinchey III 级和 IV 级疾病),66 例患者行 Hartmann 手术(分别有 46 例和 20 例)。行一期吻合术的患者的总体平均每位患者的成本(€20544,95%可信区间 19569 至 21519)低于 Hartmann 手术(€28670,26636 至 30704),差值为 €-8126(-14660 至-1592)。ICER 为 €-39094(95%偏倚校正和加速可信区间-1213 至-116),表明一期吻合术更具成本效益。ICUR 为 €-101435(95%偏倚校正和加速可信区间-1113264 至 251840)。
对于伴有脓性或粪便性腹膜炎的穿孔性憩室炎,与 Hartmann 手术相比,行一期吻合术具有更高的成本效益。